ViroPharma Starts Packaging Cinryze With West Pharma Mix2Vial Needle-less Reconstitution System
Cinryze is a highly purified, pasteurised and nanofiltered plasma-derived C1 esterase inhibitor product that has been approved by FDA in October 2008 for routine prophylaxis against hereditary angioedema(HAE)
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.